Company Profile

Accord Biosciences Inc (AKA: Accord Biomaterials Inc)
Profile last edited on: 6/17/21      CAGE: 4WA80      UEI:

Business Identifier: Biomarker assays and diagnostic tools.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5703 North Main Street Suite E
Sylvania, OH 43560
   (419) 517-7303
Location: Multiple
Congr. District: 05
County: Lucas

Public Profile

As of 2014, firm appears to be no longer operational. Accord was developing nitric oxide (NO) sensors that detect free and bound NO, including s-nitrosothiols, in blood. Accord also specialized in the stabilization of these reactive NO species to enable accurate measurement representative of physiologic conditions. The company had been venture-funded, and collaborating with the Cleveland Clinic. Accord had planned to commercialize sensors for the research market in 2013 and to pursue in-vitro diagnostics indications with partners. Potential applications include cardiovascular, endocrine, inflammatory and hypertensive diseases. Accord held expertise in NO biochemistry and analytics, electrochemistry applied to life sciences applications, medical device development and biomarker validation.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 2 NIH $1,482,251
Project Title: S-Nitrosothiol Analyzer For The Clinical Diagnosis Of Cardiovascular Disease Mark
2009 2 NIH $1,136,155
Project Title: Stent Coating to Prevent Restenosis and Subacute Thrombosis
2009 2 NIH $951,262
Project Title: Implantable Glucose Sensor with Prolonged Accuracy
2008 1 NIH $419,141
Project Title: Stent Coating To Prevent Restenosis And Subacute Thrombosis

Key People / Management

  Hiltesh Handa

  Melissa M Reynolds

Company News

There are no news available.